Clinical Trials Directory

Trials / Completed

CompletedNCT02855281

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Wissenschaftliches Institut Bethanien e.V · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective diagnostic pilot study to create hypotheses regarding immunocytochemistry (ICC) PD-L1 analysis of pleural effusions in NSCLC patients as compared to the reference standard of PD-L1 immunohistochemistry (IHC). This comparison will be done to assess sensitivity and specificity of PD-L1 detection by ICC in pleural effusions.

Conditions

Timeline

Start date
2016-10-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2016-08-04
Last updated
2021-03-05
Results posted
2021-03-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02855281. Inclusion in this directory is not an endorsement.

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer (NCT02855281) · Clinical Trials Directory